US20060141074A1 - Composition for neutralizing house dust mite feces - Google Patents
Composition for neutralizing house dust mite feces Download PDFInfo
- Publication number
- US20060141074A1 US20060141074A1 US11/349,832 US34983206A US2006141074A1 US 20060141074 A1 US20060141074 A1 US 20060141074A1 US 34983206 A US34983206 A US 34983206A US 2006141074 A1 US2006141074 A1 US 2006141074A1
- Authority
- US
- United States
- Prior art keywords
- green tea
- botanical
- botanical extract
- dust mite
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N61/00—Biocides, pest repellants or attractants, or plant growth regulators containing substances of unknown or undetermined composition, e.g. substances characterised only by the mode of action
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/28—Myrtaceae [Myrtle family], e.g. teatree or clove
Definitions
- the present invention relates to a method of neutralizing allergens produced by house dust mites. More particularly, the present invention relates to a method and composition for neutralizing house dust mite feces allergens by atomizing an aqueous solution comprising a botanical extract having protease inhibitory activity such that the atomized botanical extract contacts the house dust mite feces and renders it substantially non-allergenic.
- House dust mites are co-inhabitants of almost every house and, because of their size and translucent body structure, cannot be seen with the naked eye. Dust mites are found in almost all home furnishing textiles and thrive in mattresses, pillows, cushions, carpets, upholstery, and soft toys etc. An adult mite can live up to about three months.
- the reactions caused by house dust mite feces in sensitive people can range from itchy and watery eyes, repeated sneezing and running nose, cough and bronchial asthma, to eczema.
- the dust on which house dust mites thrive may be cotton, wool lint, animal and human dander or hair, crumbs, pollens, and molds.
- House dust mites typically feed on human skin scales. In addition to a food source, the other essential requirement for dust mite growth is adequate humidity. Dust mites are 75% water by weight and although they do not drink water, they must absorb water vapor from the air to survive. Specialized glands above their pairs of legs produce secretions high in sodium and potassium chloride, which act to absorb water vapor from surrounding air. This can only be accomplished if the surrounding humidity is sufficiently high. Relative humidities of about 65-80% at temperatures ranging from about 20 to 35° C. are optimal for dust mite growth.
- a major dust mite allergen is present in dust mite fecal particles.
- Each dust mite produces about 20 fecal particles per day, and more than 100,000 mites may be present in a gram of dust.
- These fecal particles vary from about 10 to about 40 microns in size, comparable to the size of pollen grains, and become airborne during domestic activity such as making beds and vacuuming carpets.
- Enzymes with serine protease and/or cysteine protease activities from house dust mite feces have been shown to damage the airway epithelium. This damage increases the propensity for house dust mite allergens (including proteases) to penetrate the protective epithelium lining, interact with immune cells, and can induce the production of specific IgE molecules which can initiate an inflammatory cascade culminating in an allergic response.
- Group I allergens Dermatophagoides farinae I, and Dermatophagoides pternoyssinus I
- Dermatophagoides farinae I, and Dermatophagoides pternoyssinus I are heat labile, 24,000 molecular weight glycoproteins, and appear to be structural homologues and have very similar N-terminal amino acid sequences.
- Group I allergens are regarded as the most important and are excreted in their highest concentrations by the mite's gastrointestinal tract in the form of mite's fecal particles.
- Group II allergens Dermatophagoides farinae II, and Dermatophagoides pternoyssinus II
- Dermatophagoides farinae II, and Dermatophagoides pternoyssinus II are 15,000 molecular weight proteins with almost identical N-terminal amino acid sequences that are also secreted by the mite's gastrointestinal tract in the form of fecal allergens, although not in as high a concentration as the group I allergens.
- Most dust mite allergic individuals produce antibodies to both the group I and group II allergens.
- the control of dust mite population in the domestic environment is one method of preventing house dust allergies.
- the degree of cleanliness impacts the number of house dust mites and the resulting allergen level.
- Common control measures include vacuum cleaning, frequent washing, and treating the carpets and bed spreads with insecticides, acaricides, and fungicides. Reducing dust mite population by interfering with the food chain has also been suggested.
- Rao et al. in U.S. Pat. No. 6,060,075 disclose a composition for controlling house dust mite population.
- the composition comprises a plant derived acaricidal agent, which is disclosed as neem seed kernel extract, and a plant derived disinfectant agent, which is disclosed as an alcoholic extract of resins like stryax benzoin.
- Rao et al. disclose that a bi-weekly spray of 200 microliters/100 milligrams of culture is required for eight weeks to completely eliminate the house dust mites, and discloses that re-establishment of house dust mites after treatment with acaricides is a common problem due to the existence of nymph and eggs.
- Rao et al. fail to disclose any compositions or methods for neutralizing the feces allergen of dust mites, and simply disclose a very narrow composition for killing house dust mites, which does not necessarily neutralize the feces.
- Miller in published U.S. Patent Application US2002/0022043 discloses a method for killing house dust mites in clothing and other soft materials. Miller exposes woolen or other fabrics to the vapors of certain plant oils, including wintergreen oil, lavandin oil, Ylang-Ylang oil and others. The oils are aromatherapy-grade oils produced by steam distillation. Miller generates vapors of the oils numerous ways including: placing a few drops of the oil on a paper towel, piece of cotton, or on a glass or plastic dish and then placing the treated substrate in a closed environment with the articles to be treated; spraying a mist of the oil onto the substrate to be treated, or by heating the oil to cause vaporization.
- Miller sets forth a method for killing house dust mites, but does not disclose methods or compositions for neutralizing house dust mite feces. Additionally, the compositions set forth by Miller are oils which can be messy to work with, can stain certain fabrics, and can be very difficult to effectively vaporize.
- McKechnie et al. in UK Patent Application GB 2,363,074 disclose a method for deactivating house dust mite allergens by volatilizing an oil which comprises tea tree oil or another oil comprising terpene compounds and contacting the volatilized oil with the house dust mite feces.
- McKechnie et al. volatilize the oil in numerous ways including: heating the oil to form vapors; vaporizing the oil from a heated wick dipped into a reservoir of the oil; and by utilizing an ultra-sonic jet nebuliser which contains water with the oil floated on the surface of the water.
- tea tree and other oils which are not water soluble can be difficult to work with and difficult to effectively vaporize.
- the method preferably will involve simple, water soluble, compositions which are easy to work with and easily atomizable, in contrast to the oils disclosed in the prior art.
- the present invention relates to neutralizing allergenic dust mite feces by contacting the dust mite feces with botanical extracts having protease inhibitory activity to reduce the allergenicity of the dust mite feces.
- botanical extracts having protease inhibitory activity to reduce the allergenicity of the dust mite feces.
- Substantially water soluble botanical extracts, such as Green Tea Extra or Grape Seed Extract, for example, are introduced into water to form an aqueous botanical extract solution.
- the botanical extract which may be in powder form or in aqueous form, used to form the aqueous botanical extract solution has a BAPNA-Trypsin inhibition (IC 50 ⁇ 10 ⁇ 3 (%, v/v or w/v)) of from about 0.01 to about 500, and preferably has a solubility in water of at least about 0.5% by weight if the botanical extract is a solid or at least about 10% by weight if the botanical extract is a liquid. Because the botanical extracts suitable for use in the present invention have a high solubility in water, they are easily and conveniently aerosolized such that large areas can easily be treated.
- BAPNA-Trypsin inhibition IC 50 ⁇ 10 ⁇ 3 (%, v/v or w/v)
- the aqueous botanical extract solution is introduced into an atomizer such that the aqueous botanical extract solution can be atomized into a room and easily contact numerous areas where dust mites are known to be present including, for example, bed linens, pillows, and carpets.
- the median drop size of the atomized aqueous botanical extract solution is less than 1000 micrometers to ensure sufficient contact with the dust mite feces.
- the present invention is directed to a method of neutralizing dust mite feces.
- the method comprises introducing a soluble botanical extract into water to form an aqueous botanical solution and contacting the dust mite feces with the aqueous botanical extract solution.
- the botanical extract has a BAPNA-Trypsin Inhibition (IC 50 ⁇ 10 ⁇ 3 (%, v/v)) of from about 0.01 to about 500.
- the invention is further directed to a method of neutralizing dust mite feces.
- the method comprises introducing a soluble botanical extract into water to form an aqueous botanical solution and contacting the dust mite feces with the aqueous botanical extract solution.
- the botanical extract has a BAPNA-Trypsin Inhibition (IC 50 ⁇ 10 ⁇ 3 (%, w/v)) of from about 0.01 to about 500.
- the invention is further directed to a method of neutralizing dust mite feces.
- the method comprises introducing a water soluble botanical extract into water to form an aqueous botanical extract solution and contacting the dust mite feces with the aqueous botanical extract solution.
- the botanical extract has a BAPNA-Trypsin Inhibition (IC 50 ⁇ 10 ⁇ 3 (%, v/v or w/v)) of from about 0.01 to about 500 and a solubility in water of at least about 0.5% by weight.
- the invention is further directed to a method of neutralizing dust mite feces.
- the method comprises introducing a water soluble botanical extract into water to form an aqueous botanical extract solution and contacting the dust mite feces with the aqueous botanical extract solution.
- the botanical extract has a BAPNA-Trypsin Inhibition (IC 50 ⁇ 10 ⁇ 3 (%, v/v or w/v)) of from about 0.01 to about 500 and a solubility in water of at least about 1% (v/v or w/v).
- the invention is further directed to an aqueous composition for neutralizing dust mite feces.
- the composition comprises a water soluble botanical extract having a BAPNA-Trypsin Inhibition (IC 50 ⁇ 10 ⁇ 3 (%, v/v or w/v)) of from about 0.01 to about 500.
- the invention is further directed to a method of neutralizing dust mite feces.
- the method comprises introducing a protease inhibitory, water soluble agent into water to form a protease inhibitory solution and contacting the dust mite feces with the protease inhibitory solution.
- substantially water soluble botanical extracts having a BAPNA-Trypsin Inhibition (IC 50 ⁇ 10 ⁇ 3 (%, v/v or w/v)) of from about 0.01 to about 500 as described herein can be introduced into water to form an aqueous botanical extract solution which can be utilized in atomized form to treat large areas quickly and easily to neutralize dust mite feces allergens.
- BAPNA-Trypsin Inhibition IC 50 ⁇ 10 ⁇ 3 (%, v/v or w/v)
- the botanical extracts used to form the botanical extract solution have a solubility in water of at least about 0.5% by weight, and more preferably at least about 1% by weight to ensure sufficient solubility of the botanical extract into the aqueous solution. Further, it is preferred that the median drop size of the atomized aqueous botanical extract solution be less than about 1000 micrometers to ensure effective coverage.
- Dust mites and feces from dust mites are present throughout many areas of homes as discussed above. Dust mite feces has been repeatedly shown to contain high levels of serine proteases, which are known to cause allergic responses in some humans when inhaled into the nose, throat, and lungs. Through vigorous investigation and experimentation, the inventors discovered that numerous botanical extracts have strong protease inhibitory activity and have high solubility in water. This combination of protease inhibitory activity and solubility in water allows a concentrated aqueous botanical extract solution to be prepared in accordance with the present invention that can be contacted with the feces of dust mites resulting in the neutralization of the feces such that the dust mite feces become substantially non-allergenic.
- the botanical extracts act to neutralize the allergenic feces of the dust mite, and do not simply kill some dust mites while leaving the feces to continue to act as an allergen if inhaled. Because completely killing every dust mite in an area, such as a bedroom, and keeping the dust mites from returning is extremely difficult, if not impossible, the present invention is substantially advantageous in that the specific allergens themselves, the feces, are neutralized through contact with the atomized botanical extract. As discussed below, in some embodiments of the present invention, the botanical extract solution described herein can be utilized in combination with an additional agent capable of killing the dust mites. This combination provides a highly effective anti-allergenic system.
- water soluble botanical extracts which provide the desired level of protease inhibitory activity can be used in the aqueous solutions of the present invention to neutralize dust mite feces.
- the botanical extracts useful in the practice of the present invention may be in solid form or in aqueous form. Regardless of whether the botanical extract is in solid form or aqueous form, as used herein, the term “water soluble” means soluble in water at a level of at least about 0.5% by weight, and preferably at least about 1% by weight. Typically, aqueous botanical extracts will have a much higher solubility in water.
- liquid botanical extracts described herein may be provided as mixtures of water, butylene glycol, glycerin, and the extracted botanical, or similar formulations.
- the extract formulation is soluble in water in part due to the use of butylene glycol as the solvent.
- the botanical extracts themselves suitable for use in the present invention may be water soluble or hydrophilic solvent soluble.
- Common hydrophilic solvents include propylene glycol, butylene glycol, ethylene glycol, hexylene glycol, pentylene glycol, methyl propanediol, dipropylene glycol, and the like. Additionally, solvents such as ethanol or isopropyl alcohol may be utilized as solvents.
- the term “neutralize dust mite feces” means that the dust mite feces is rendered less allergenistic; that is, the dust mite feces, or components thereof, are a less potent allergen and are less likely to result in an allergic reaction in a human.
- Many botanical extracts are commercially available and typically are in one of three forms: (1) powderous solid; (2) aqueous solution comprising the botanical; or (3) oil.
- the botanical extract is typically about 100% pure botanical extract, but may include a small percentage of other solids resulting from the purification procedures used to collect the botanical extract from the botanical source.
- the botanical extract is available only as an aqueous solution or oil, the exact amount of botanical extract contained in the liquid may not be precisely known. Regardless, liquid botanical extracts can be tested and evaluated for use in the present invention as described herein without knowing the precise amount of botanical present in the solution.
- the botanical extracts suitable for use in the aqueous solutions are substantially soluble in water.
- the botanical extract is soluble in water at a level of at least about 0.5% by weight, and more preferably at least about 1% by weight. This solubility ensures that the botanical extract will be sufficiently soluble for introduction into the aqueous solutions as described herein such that the solution can be easily atomized. As one skilled in the art will recognize, higher solubilities are preferred.
- Suitable botanical extracts for use with the methods and compositions of the present invention include those botanical extracts having serine protease inhibitory properties; that is, botanical extracts that inhibit the activity of the enzyme serine protease and reduce its ability to perform its intended cleaving function on a given substrate.
- botanical extracts suitable for use include those botanical extracts having a BAPNA-Trypsin Inhibition (IC 50 ⁇ 10 ⁇ 3 (%, v/v or w/v) of from about 0.01 to about 500, more preferably from about 0.01 to about 200, still more preferably from about 0.01 to about 100, more preferably from about 0.01 to about 20, and most preferably from about 0.01 to about 10.
- IC 50 values set forth herein can easily be converted to concentration percentages (representing the concentration of a given botanical required to reduce the activity of the target by 50%) by simply multiplying the value by 10 ⁇ 3 ; for example, an IC 50 value as reported herein of 500 would be equal to a concentration of botanical extract of 0.5%; that is, a concentration of 0.5% of the botanical would be required to reduce the activity of the target enzyme by 50%.
- BAPNA-Trypsin Inhibition IC 50 values described herein are determined for botanical extracts according to the BAPNA-Trypsin Inhibition Testing procedure set forth herein, and well known to those skilled in the art.
- Botanical extracts whether in solid (powder) or liquid form, are tested for their ability to inhibit a model serine protease (porcine pancreatic trypsin) in solution as follows:
- PBS Phosphate Buffered Saline
- Serial dilutions of the starting solution for analysis are prepared using PBS at a pH of 7.4 as the diluent.
- 7 serial dilutions of the 10% (v/v) starting solution can be made to prepare 8 different concentrations of botanical extract for testing: (1) 10%; (2) 5%; (3) 2.5%; (4) 1.25%; (5) 0.63%; (6) 0.31%; (7) 0.16%; and (8) 0.078%.
- Similar serial dilutions are made to prepare numerous samples if the starting testing solution concentration is less than 10%.
- Botanical extract testing solutions are prepared as follows when the botanical extract is a solid: a 0.1% (w/v) starting solution is prepared by introducing 1 milligram of solid botanical extract into one milliliter of PBS, pH of 7.4. Serial dilutions of the starting solution are prepared using PBS, pH of 7.4, as the diluent. For example, 7 serial dilutions of the 0.1% (w/v) testing solution can be made to prepare 8 different concentrations of botanical extract for testing as described above.
- Step 2 To the empty wells of a clear well plate, such as a NUNC IMMUNO clear 96 well plate (VWR Scientific Products, Chicago, Ill.), are added 150 microliters of 100 mM Tris buffer which has been adjusted to a pH of about 8.0 utilizing HCL.
- the Tris buffer is commonly known to those skilled in the art and can be prepared using Tris powder or Tris liquid.
- Step 3 To the wells of the well plate to be utilized for testing the botanical extract (i.e., not the control wells to which 25 microliters of PBS is added in place of the botanical extract) is added 25 microliters of the botanical extract solution prepared under Step 1.
- wells 1, 2, and 3 may have 25 microliters of the 10% (v/v) botanical extract solution added to them to analyze the 10% botanical extract solution in triplicate.
- Wells 4, 5, and 6 may then have 25 microliters of the 5% (v/v) botanical extract solution added to them to analyze the 5% botanical extract solution in triplicate, etc.
- Step 4 A stock solution of the porcine pancreatic trypsin is then prepared by adding the protease (15,200 units/milligram, Sigma Chemical Company, St. Louis, Mo.) into 100 millimolar Tris buffer, pH adjusted to 8.0 with HCl to yield a concentration of 4 micrograms of trypsin/milliliter. To each well is then added 25 microliters of the protease.
- protease 15,200 units/milligram, Sigma Chemical Company, St. Louis, Mo.
- Step 5 The well plates are then incubated at room temperature for 15 minutes.
- Step 6 After incubation, 50 microliters of a 5 millimolar solution of N-benzyl-arginine-p-nitroaniline (BAPNA, Sigma Chemical Company, St. Louis, Mo.) is added to each of the wells.
- BAPNA substrate is prepared as a stock solution by preparing a 50 millimolar solution of BAPNA in dimethylsulfoxide and diluting the solution to a 5 millimolar working solution with deionized water.
- the final concentration of botanical extract in the sample being tested is 1/10 of the concentration of the botanical extract solution as prepared under Step 1.
- the 10% botanical extract solution prepared in step 1 becomes a 1% concentration of botanical extract in the well.
- Step 7 After the BAPNA is added, the plate is inserted into a SPECTRAmax PLUS Microplate Reader (Molecular Devices, Sunnyvale Calif.), or similar instrument, and optical density measurements (405 nanometers) are taken every 20 seconds for a period of 5 minutes to monitor the color change of the solution.
- SPECTRAmax PLUS Microplate Reader Molecular Devices, Sunnyvale Calif.
- optical density measurements 405 nanometers
- the amount of color change occurring at 405 nanometers per minute corresponds to the amount of product produced per minute.
- Reaction rates are determined with each concentration of botanical extract tested and the PBS control (no botanical extract). If the control wells were prepared in duplicate or triplicate, for example, the reaction rates from each of the wells were averaged. The data are used to determine an IC 50 value for each botanical extract plotting trypsin activity (y-axis) versus botanical extract concentration (percent w/v or v/v) (x-axis). IC 50 is defined as the concentration of the botanical extract that inhibits 50% of the trypsin activity.
- the following botanical extracts have been found to have the desired protease inhibitory properties and are suitable for use in an aqueous solution for neutralizing dust mite feces as described herein: Apple Green Tea, Arkin Special, Arnica Special, Avocado, avocado GW, Black Currant Green Tea, Cabbage Rose, Cat's Claw, Cemila Oleifera, Centella, Cranberry Green Tea, Dandelion, Garcinia, Grape Seed, Grapefruit Green Tea, Green Tea, Green Tea Concentrate, Green Tea HS, Hexaplant Richter, Hibiscus Special, Hydrocotyle GR, Lavender, Horse Chestnut, Milk Thistle, Orange Green Tea, Phytexcell Arnica, Purple Coneflower, Sage GW, Sage Special, Sedaplant Richter, St. John's Wort, Witchhazel GW, Yarrow, Green Tea Extra, Grape Seed Extract and White Tea 50%.
- Preferred botanical extracts include Green Tea Extra, Grape Seed Extract, and White Tea 50%.
- the soluble botanical extracts having sufficient protease inhibitory activity described herein are introduced into water to form an aqueous botanical extract solution which is subsequently contacted with the dust mite feces to allow the botanical extract to interact with and reduce the allergenicity of the dust mite feces.
- the water source is not critical, and can be deionized water, distilled water, tap water, and the like. Although not required, it is preferred that the aqueous botanical extract solutions as described herein be adequately preserved to substantially prevent microbial contamination and thus improve the overall quality of the solution.
- water soluble preservatives commercially available which would be suitable for use with the aqueous botanical extract solutions described herein.
- the aqueous botanical extract solution can easily be atomized into an area to be treated, such as a bedroom or other room.
- atomized means that the aqueous botanical extract solution is reduced to a spray form from liquid form, or volatilized.
- Atomization of the aqueous botanical extract solutions of the present invention can be accomplished utilizing various means including, for example, atomizers, aerosol sprayers, mechanical sprayers, misters, humidifiers, foggers, fumigating apparatuses, and the like. Both cold mist formulations and warm mist formulations including the aqueous botanical extract solutions are within the scope of the present invention.
- the aqueous botanical solution can also contain a small amount of dyes to color the product and/or a fragrance to impart a pleasing odor to the solution. Both of these additives potentially enhance consumer appeal of the product.
- the precise method of volatilizing the aqueous botanical extract solutions of the present invention to allow the botanical extract to contact the dust mite feces is not critical so long as the method employed can volatilize the aqueous solution sufficiently. Because house dust mites are typically very small in size, having a length of only about 250 microns to about 300 microns, it is preferable, although not critical, that the size of the droplets produced by the atomizing means be of such a size that they will sufficiently contact a majority of the dust mites and feces present in an area.
- the atomized droplets of aqueous botanical extract solution have a medium drop size of no more than 1000 micrometers, more preferably no more than 500 micrometers, more preferably no more than about 200 micrometers, and most preferably no more than about 100 micrometers or less. These median drop sizes will allow a significant amount of the botanical extract to contact the dust mite feces present.
- a pesticidal composition could be introduced into the aqueous botanical extract solution and atomized simultaneously.
- the aqueous botanical extract solutions described herein can be used in combination with a pesticidal, acaricidal, or other suitable agent which kills the dust mites upon application or treatment.
- a pesticidal composition capable of killing dust mites upon contact could first be sprayed or otherwise applied to an area such as a bedroom, to kill dust mites.
- the aqueous botanical extracts of the present invention could be atomized as described herein into the area to neutralize the feces of the dust mites.
- aqueous botanical extract solutions described herein are highly effective in neutralizing the dust mite feces when used alone, when used in combination with an agent that kills dust mites, the combination is also highly effective in controlling the amount of dust mite allergens present.
- the botanical extracts are set forth in Table 1.
- NUNC IMMUNO clear 96 well plate To the empty wells of a NUNC IMMUNO clear 96 well plate (VWR Scientific Products, Chicago, Ill.) was added 150 microliters of a 100 millimolar Tris buffer (Sigma Chemical Company, St. Louis, Mo.) with the pH adjusted to 8.0 utilizing HCl. Next, to allow for testing in triplicate, each concentration of botanical solution was added to three separate wells containing the Tris buffer. For control purposes, three wells had 25 microliters of the PBS solution introduced therein in place of any botanical extract solution.
- Tris buffer Sigma Chemical Company, St. Louis, Mo.
- porcine pancreatic trypsin 15,200 units/milligram, Sigma Chemical Company, St. Louis, Mo.
- 100 millimolar Tris buffer, pH adjusted to 8.0 with HCL to yield a concentration of 4 micrograms/milliliter.
- To each well of the plate was then added 25 microliters of the 4 micrograms/milliliter trypsin.
- BAPNA substrate was prepared as a stock solution by preparing a 50 millimolar solution of BAPNA in dimethylsulfoxide and diluting the solution to a 5 millimolar working solution with deionized water. This resulted in a total concentration of botanical extracts being tested from a working stock of 10% (v/v) botanical solution of (1) 1%; (2) 0.5%; (3) 0.25%; (4) 0.125%; (5) 0.063%; (6) 0.031%; (7) 0.016%; and (8) 0.0078%.
- the plate was inserted into a SPECTRAmax PLUS 384 Microplate Reader (Molecular Devices, Sunnyvale, Calif.), and the optical density of each well was measured at 405 nanometers every 20 seconds for 5 minutes.
- IC 50 values determined for the botanical extracts tested ranged from 0.048 to 1000 (no inhibition detected). This would indicate that the botanical extract with an IC 50 value of 0.048 (Grape Seed Extract) is highly effective in neutralizing dust mite feces whereas the botanical extract with a value of 1000 has little to no effect.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pest Control & Pesticides (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cosmetics (AREA)
- Extraction Or Liquid Replacement (AREA)
Abstract
Methods for neutralizing dust mite feces are disclosed. In one embodiment, a botanical extract having a BAPNA-Trypsin Inhibition (IC50×10−3 (%, v/v or w/v) of from about 0.01 to about 500 and a sufficient solubility in water is introduced into water to form an aqueous botanical extract solution. The aqueous botanical extract solution is atomized into an area being treated such that the botanical extract contacts and neutralizes the dust mite feces located in the area. Particularly preferred botanical extracts for use in the botanical extract aqueous solutions of the present invention include Green Tea Extra and Grape Seed Extract.
Description
- This divisional patent application claims priority from U.S. patent application Ser. No. 10/299,868 filed on Nov. 19, 2002, the entirety of which is hereby incorporated by reference.
- The present invention relates to a method of neutralizing allergens produced by house dust mites. More particularly, the present invention relates to a method and composition for neutralizing house dust mite feces allergens by atomizing an aqueous solution comprising a botanical extract having protease inhibitory activity such that the atomized botanical extract contacts the house dust mite feces and renders it substantially non-allergenic.
- It has been known for many years that common house dust is an important cause of asthma, rhinitis and eczema in allergic individuals. Common house dust mites (Dermatophagoides farinae and Dermatophagoides pteronyssinus) are prevalent in house dust. Dust mites are not insects, but are eight-legged arachnids, and are related to ticks and spiders. Adult mites are approximately 250-300 micrometers in length, and are photophobic.
- House dust mites are co-inhabitants of almost every house and, because of their size and translucent body structure, cannot be seen with the naked eye. Dust mites are found in almost all home furnishing textiles and thrive in mattresses, pillows, cushions, carpets, upholstery, and soft toys etc. An adult mite can live up to about three months. The reactions caused by house dust mite feces in sensitive people can range from itchy and watery eyes, repeated sneezing and running nose, cough and bronchial asthma, to eczema. The dust on which house dust mites thrive may be cotton, wool lint, animal and human dander or hair, crumbs, pollens, and molds.
- House dust mites typically feed on human skin scales. In addition to a food source, the other essential requirement for dust mite growth is adequate humidity. Dust mites are 75% water by weight and although they do not drink water, they must absorb water vapor from the air to survive. Specialized glands above their pairs of legs produce secretions high in sodium and potassium chloride, which act to absorb water vapor from surrounding air. This can only be accomplished if the surrounding humidity is sufficiently high. Relative humidities of about 65-80% at temperatures ranging from about 20 to 35° C. are optimal for dust mite growth.
- A major dust mite allergen is present in dust mite fecal particles. Each dust mite produces about 20 fecal particles per day, and more than 100,000 mites may be present in a gram of dust. These fecal particles vary from about 10 to about 40 microns in size, comparable to the size of pollen grains, and become airborne during domestic activity such as making beds and vacuuming carpets. Enzymes with serine protease and/or cysteine protease activities from house dust mite feces have been shown to damage the airway epithelium. This damage increases the propensity for house dust mite allergens (including proteases) to penetrate the protective epithelium lining, interact with immune cells, and can induce the production of specific IgE molecules which can initiate an inflammatory cascade culminating in an allergic response.
- Group I allergens (Dermatophagoides farinae I, and Dermatophagoides pternoyssinus I) are heat labile, 24,000 molecular weight glycoproteins, and appear to be structural homologues and have very similar N-terminal amino acid sequences. Group I allergens are regarded as the most important and are excreted in their highest concentrations by the mite's gastrointestinal tract in the form of mite's fecal particles.
- Group II allergens (Dermatophagoides farinae II, and Dermatophagoides pternoyssinus II) are 15,000 molecular weight proteins with almost identical N-terminal amino acid sequences that are also secreted by the mite's gastrointestinal tract in the form of fecal allergens, although not in as high a concentration as the group I allergens. Most dust mite allergic individuals produce antibodies to both the group I and group II allergens.
- The control of dust mite population in the domestic environment is one method of preventing house dust allergies. The degree of cleanliness impacts the number of house dust mites and the resulting allergen level. Common control measures include vacuum cleaning, frequent washing, and treating the carpets and bed spreads with insecticides, acaricides, and fungicides. Reducing dust mite population by interfering with the food chain has also been suggested.
- Rao et al. in U.S. Pat. No. 6,060,075 disclose a composition for controlling house dust mite population. The composition comprises a plant derived acaricidal agent, which is disclosed as neem seed kernel extract, and a plant derived disinfectant agent, which is disclosed as an alcoholic extract of resins like stryax benzoin. Rao et al. disclose that a bi-weekly spray of 200 microliters/100 milligrams of culture is required for eight weeks to completely eliminate the house dust mites, and discloses that re-establishment of house dust mites after treatment with acaricides is a common problem due to the existence of nymph and eggs. Rao et al., however, fail to disclose any compositions or methods for neutralizing the feces allergen of dust mites, and simply disclose a very narrow composition for killing house dust mites, which does not necessarily neutralize the feces.
- Miller in published U.S. Patent Application US2002/0022043 discloses a method for killing house dust mites in clothing and other soft materials. Miller exposes woolen or other fabrics to the vapors of certain plant oils, including wintergreen oil, lavandin oil, Ylang-Ylang oil and others. The oils are aromatherapy-grade oils produced by steam distillation. Miller generates vapors of the oils numerous ways including: placing a few drops of the oil on a paper towel, piece of cotton, or on a glass or plastic dish and then placing the treated substrate in a closed environment with the articles to be treated; spraying a mist of the oil onto the substrate to be treated, or by heating the oil to cause vaporization. Similar to Rao, Miller sets forth a method for killing house dust mites, but does not disclose methods or compositions for neutralizing house dust mite feces. Additionally, the compositions set forth by Miller are oils which can be messy to work with, can stain certain fabrics, and can be very difficult to effectively vaporize.
- McKechnie et al. in UK Patent Application GB 2,363,074 disclose a method for deactivating house dust mite allergens by volatilizing an oil which comprises tea tree oil or another oil comprising terpene compounds and contacting the volatilized oil with the house dust mite feces. McKechnie et al. volatilize the oil in numerous ways including: heating the oil to form vapors; vaporizing the oil from a heated wick dipped into a reservoir of the oil; and by utilizing an ultra-sonic jet nebuliser which contains water with the oil floated on the surface of the water. As with Miller discussed above, tea tree and other oils which are not water soluble can be difficult to work with and difficult to effectively vaporize.
- Based on the foregoing, a simple, cost effective method of neutralizing the feces allergens of house dust mites is needed. The method preferably will involve simple, water soluble, compositions which are easy to work with and easily atomizable, in contrast to the oils disclosed in the prior art.
- The present invention relates to neutralizing allergenic dust mite feces by contacting the dust mite feces with botanical extracts having protease inhibitory activity to reduce the allergenicity of the dust mite feces. Substantially water soluble botanical extracts, such as Green Tea Extra or Grape Seed Extract, for example, are introduced into water to form an aqueous botanical extract solution. The botanical extract, which may be in powder form or in aqueous form, used to form the aqueous botanical extract solution has a BAPNA-Trypsin inhibition (IC50×10−3 (%, v/v or w/v)) of from about 0.01 to about 500, and preferably has a solubility in water of at least about 0.5% by weight if the botanical extract is a solid or at least about 10% by weight if the botanical extract is a liquid. Because the botanical extracts suitable for use in the present invention have a high solubility in water, they are easily and conveniently aerosolized such that large areas can easily be treated. In one embodiment of the present invention, the aqueous botanical extract solution is introduced into an atomizer such that the aqueous botanical extract solution can be atomized into a room and easily contact numerous areas where dust mites are known to be present including, for example, bed linens, pillows, and carpets. In a preferred embodiment, the median drop size of the atomized aqueous botanical extract solution is less than 1000 micrometers to ensure sufficient contact with the dust mite feces.
- Briefly, therefore, the present invention is directed to a method of neutralizing dust mite feces. The method comprises introducing a soluble botanical extract into water to form an aqueous botanical solution and contacting the dust mite feces with the aqueous botanical extract solution. The botanical extract has a BAPNA-Trypsin Inhibition (IC50×10−3 (%, v/v)) of from about 0.01 to about 500.
- The invention is further directed to a method of neutralizing dust mite feces. The method comprises introducing a soluble botanical extract into water to form an aqueous botanical solution and contacting the dust mite feces with the aqueous botanical extract solution. The botanical extract has a BAPNA-Trypsin Inhibition (IC50×10−3 (%, w/v)) of from about 0.01 to about 500.
- The invention is further directed to a method of neutralizing dust mite feces. The method comprises introducing a water soluble botanical extract into water to form an aqueous botanical extract solution and contacting the dust mite feces with the aqueous botanical extract solution. The botanical extract has a BAPNA-Trypsin Inhibition (IC50×10−3 (%, v/v or w/v)) of from about 0.01 to about 500 and a solubility in water of at least about 0.5% by weight.
- The invention is further directed to a method of neutralizing dust mite feces. The method comprises introducing a water soluble botanical extract into water to form an aqueous botanical extract solution and contacting the dust mite feces with the aqueous botanical extract solution. The botanical extract has a BAPNA-Trypsin Inhibition (IC50×10−3 (%, v/v or w/v)) of from about 0.01 to about 500 and a solubility in water of at least about 1% (v/v or w/v).
- The invention is further directed to an aqueous composition for neutralizing dust mite feces. The composition comprises a water soluble botanical extract having a BAPNA-Trypsin Inhibition (IC50×10−3 (%, v/v or w/v)) of from about 0.01 to about 500.
- The invention is further directed to a method of neutralizing dust mite feces. The method comprises introducing a protease inhibitory, water soluble agent into water to form a protease inhibitory solution and contacting the dust mite feces with the protease inhibitory solution.
- Other objects and features of this invention will be in part apparent and in part pointed out hereinafter.
- In accordance with the present invention, it has been discovered that certain botanical extracts, whether in powder form or in liquid form, can be effectively utilized to reduce the allergenicity of allergens including dust mite feces. Surprisingly, substantially water soluble botanical extracts having a BAPNA-Trypsin Inhibition (IC50×10−3 (%, v/v or w/v)) of from about 0.01 to about 500 as described herein can be introduced into water to form an aqueous botanical extract solution which can be utilized in atomized form to treat large areas quickly and easily to neutralize dust mite feces allergens. In preferred embodiments, the botanical extracts used to form the botanical extract solution have a solubility in water of at least about 0.5% by weight, and more preferably at least about 1% by weight to ensure sufficient solubility of the botanical extract into the aqueous solution. Further, it is preferred that the median drop size of the atomized aqueous botanical extract solution be less than about 1000 micrometers to ensure effective coverage.
- Dust mites and feces from dust mites are present throughout many areas of homes as discussed above. Dust mite feces has been repeatedly shown to contain high levels of serine proteases, which are known to cause allergic responses in some humans when inhaled into the nose, throat, and lungs. Through vigorous investigation and experimentation, the inventors discovered that numerous botanical extracts have strong protease inhibitory activity and have high solubility in water. This combination of protease inhibitory activity and solubility in water allows a concentrated aqueous botanical extract solution to be prepared in accordance with the present invention that can be contacted with the feces of dust mites resulting in the neutralization of the feces such that the dust mite feces become substantially non-allergenic. One important aspect of the present invention is that the botanical extracts act to neutralize the allergenic feces of the dust mite, and do not simply kill some dust mites while leaving the feces to continue to act as an allergen if inhaled. Because completely killing every dust mite in an area, such as a bedroom, and keeping the dust mites from returning is extremely difficult, if not impossible, the present invention is substantially advantageous in that the specific allergens themselves, the feces, are neutralized through contact with the atomized botanical extract. As discussed below, in some embodiments of the present invention, the botanical extract solution described herein can be utilized in combination with an additional agent capable of killing the dust mites. This combination provides a highly effective anti-allergenic system.
- Numerous water soluble botanical extracts which provide the desired level of protease inhibitory activity can be used in the aqueous solutions of the present invention to neutralize dust mite feces. The botanical extracts useful in the practice of the present invention may be in solid form or in aqueous form. Regardless of whether the botanical extract is in solid form or aqueous form, as used herein, the term “water soluble” means soluble in water at a level of at least about 0.5% by weight, and preferably at least about 1% by weight. Typically, aqueous botanical extracts will have a much higher solubility in water. It will be recognized by one skilled in the art that many of the liquid botanical extracts described herein may be provided as mixtures of water, butylene glycol, glycerin, and the extracted botanical, or similar formulations. The extract formulation is soluble in water in part due to the use of butylene glycol as the solvent. As such, the botanical extracts themselves suitable for use in the present invention may be water soluble or hydrophilic solvent soluble. Common hydrophilic solvents include propylene glycol, butylene glycol, ethylene glycol, hexylene glycol, pentylene glycol, methyl propanediol, dipropylene glycol, and the like. Additionally, solvents such as ethanol or isopropyl alcohol may be utilized as solvents.
- As used herein, the term “neutralize dust mite feces” means that the dust mite feces is rendered less allergenistic; that is, the dust mite feces, or components thereof, are a less potent allergen and are less likely to result in an allergic reaction in a human. Many botanical extracts are commercially available and typically are in one of three forms: (1) powderous solid; (2) aqueous solution comprising the botanical; or (3) oil. In solid form, the botanical extract is typically about 100% pure botanical extract, but may include a small percentage of other solids resulting from the purification procedures used to collect the botanical extract from the botanical source. When the botanical extract is available only as an aqueous solution or oil, the exact amount of botanical extract contained in the liquid may not be precisely known. Regardless, liquid botanical extracts can be tested and evaluated for use in the present invention as described herein without knowing the precise amount of botanical present in the solution.
- In accordance with the present invention, the botanical extracts suitable for use in the aqueous solutions are substantially soluble in water. Preferably, the botanical extract is soluble in water at a level of at least about 0.5% by weight, and more preferably at least about 1% by weight. This solubility ensures that the botanical extract will be sufficiently soluble for introduction into the aqueous solutions as described herein such that the solution can be easily atomized. As one skilled in the art will recognize, higher solubilities are preferred.
- Suitable botanical extracts for use with the methods and compositions of the present invention include those botanical extracts having serine protease inhibitory properties; that is, botanical extracts that inhibit the activity of the enzyme serine protease and reduce its ability to perform its intended cleaving function on a given substrate. Specifically, botanical extracts suitable for use include those botanical extracts having a BAPNA-Trypsin Inhibition (IC50×10−3 (%, v/v or w/v) of from about 0.01 to about 500, more preferably from about 0.01 to about 200, still more preferably from about 0.01 to about 100, more preferably from about 0.01 to about 20, and most preferably from about 0.01 to about 10. Whether the percentage is reported in volume/volume (v/v) or weight/volume (w/v) depends on whether the botanical extract is a powder or a liquid. One skilled in the art will recognize that the IC50 values set forth herein can easily be converted to concentration percentages (representing the concentration of a given botanical required to reduce the activity of the target by 50%) by simply multiplying the value by 10−3; for example, an IC50 value as reported herein of 500 would be equal to a concentration of botanical extract of 0.5%; that is, a concentration of 0.5% of the botanical would be required to reduce the activity of the target enzyme by 50%.
- The BAPNA-Trypsin Inhibition IC50 values described herein are determined for botanical extracts according to the BAPNA-Trypsin Inhibition Testing procedure set forth herein, and well known to those skilled in the art.
- BAPNA-Trypsin Inhibition Test For Determination of IC50 Values of Botanical Extracts
- Botanical extracts, whether in solid (powder) or liquid form, are tested for their ability to inhibit a model serine protease (porcine pancreatic trypsin) in solution as follows:
- Step 1: Botanical extract testing solutions are prepared as follows when the botanical extract is a liquid: a 10% (v/v) starting solution is prepared by introducing 100 microliters of liquid botanical extract into one milliliter of Phosphate Buffered Saline (PBS), pH=7.4. If the liquid botanical extract is not soluble at a concentration of 10% (v/v) in PBS, a starting solution of 9% (v/v) is prepared and utilized as the starting solution described herein. If the 9% (v/v) starting testing solution is not soluble in PBS, starting testing solutions of 8% (v/v), 7% (v/v), etc. are prepared until the desired solubility is obtained. Serial dilutions of the starting solution for analysis are prepared using PBS at a pH of 7.4 as the diluent. For example, 7 serial dilutions of the 10% (v/v) starting solution can be made to prepare 8 different concentrations of botanical extract for testing: (1) 10%; (2) 5%; (3) 2.5%; (4) 1.25%; (5) 0.63%; (6) 0.31%; (7) 0.16%; and (8) 0.078%. Similar serial dilutions are made to prepare numerous samples if the starting testing solution concentration is less than 10%.
- Botanical extract testing solutions are prepared as follows when the botanical extract is a solid: a 0.1% (w/v) starting solution is prepared by introducing 1 milligram of solid botanical extract into one milliliter of PBS, pH of 7.4. Serial dilutions of the starting solution are prepared using PBS, pH of 7.4, as the diluent. For example, 7 serial dilutions of the 0.1% (w/v) testing solution can be made to prepare 8 different concentrations of botanical extract for testing as described above.
- Step 2: To the empty wells of a clear well plate, such as a NUNC IMMUNO clear 96 well plate (VWR Scientific Products, Chicago, Ill.), are added 150 microliters of 100 mM Tris buffer which has been adjusted to a pH of about 8.0 utilizing HCL. The Tris buffer is commonly known to those skilled in the art and can be prepared using Tris powder or Tris liquid.
- Step 3: To the wells of the well plate to be utilized for testing the botanical extract (i.e., not the control wells to which 25 microliters of PBS is added in place of the botanical extract) is added 25 microliters of the botanical extract solution prepared under Step 1. For example, wells 1, 2, and 3 may have 25 microliters of the 10% (v/v) botanical extract solution added to them to analyze the 10% botanical extract solution in triplicate. Wells 4, 5, and 6 may then have 25 microliters of the 5% (v/v) botanical extract solution added to them to analyze the 5% botanical extract solution in triplicate, etc.
- Step 4: A stock solution of the porcine pancreatic trypsin is then prepared by adding the protease (15,200 units/milligram, Sigma Chemical Company, St. Louis, Mo.) into 100 millimolar Tris buffer, pH adjusted to 8.0 with HCl to yield a concentration of 4 micrograms of trypsin/milliliter. To each well is then added 25 microliters of the protease.
- Step 5: The well plates are then incubated at room temperature for 15 minutes.
- Step 6: After incubation, 50 microliters of a 5 millimolar solution of N-benzyl-arginine-p-nitroaniline (BAPNA, Sigma Chemical Company, St. Louis, Mo.) is added to each of the wells. The BAPNA substrate is prepared as a stock solution by preparing a 50 millimolar solution of BAPNA in dimethylsulfoxide and diluting the solution to a 5 millimolar working solution with deionized water. One skilled in the art will recognize that the final concentration of botanical extract in the sample being tested is 1/10 of the concentration of the botanical extract solution as prepared under Step 1. For example, the 10% botanical extract solution prepared in step 1 becomes a 1% concentration of botanical extract in the well.
- Step 7: After the BAPNA is added, the plate is inserted into a SPECTRAmax PLUS Microplate Reader (Molecular Devices, Sunnyvale Calif.), or similar instrument, and optical density measurements (405 nanometers) are taken every 20 seconds for a period of 5 minutes to monitor the color change of the solution. When trypsin cleaves the BAPNA substrate releasing the product p-nitroaniline, a color change occurs. The amount of color change occurring at 405 nanometers per minute corresponds to the amount of product produced per minute.
- Reaction rates (optical density at 405 nanometers per minute) are determined with each concentration of botanical extract tested and the PBS control (no botanical extract). If the control wells were prepared in duplicate or triplicate, for example, the reaction rates from each of the wells were averaged. The data are used to determine an IC50 value for each botanical extract plotting trypsin activity (y-axis) versus botanical extract concentration (percent w/v or v/v) (x-axis). IC50 is defined as the concentration of the botanical extract that inhibits 50% of the trypsin activity.
- In accordance with the present invention, the following botanical extracts have been found to have the desired protease inhibitory properties and are suitable for use in an aqueous solution for neutralizing dust mite feces as described herein: Apple Green Tea, Arkin Special, Arnica Special, Avocado, Avocado GW, Black Currant Green Tea, Cabbage Rose, Cat's Claw, Cemila Oleifera, Centella, Cranberry Green Tea, Dandelion, Garcinia, Grape Seed, Grapefruit Green Tea, Green Tea, Green Tea Concentrate, Green Tea HS, Hexaplant Richter, Hibiscus Special, Hydrocotyle GR, Lavender, Horse Chestnut, Milk Thistle, Orange Green Tea, Phytexcell Arnica, Purple Coneflower, Sage GW, Sage Special, Sedaplant Richter, St. John's Wort, Witchhazel GW, Yarrow, Green Tea Extra, Grape Seed Extract and White Tea 50%. Preferred botanical extracts include Green Tea Extra, Grape Seed Extract, and White Tea 50%.
- The soluble botanical extracts having sufficient protease inhibitory activity described herein are introduced into water to form an aqueous botanical extract solution which is subsequently contacted with the dust mite feces to allow the botanical extract to interact with and reduce the allergenicity of the dust mite feces. The water source is not critical, and can be deionized water, distilled water, tap water, and the like. Although not required, it is preferred that the aqueous botanical extract solutions as described herein be adequately preserved to substantially prevent microbial contamination and thus improve the overall quality of the solution. One skilled in the art will recognize that there are a number of water soluble preservatives commercially available which would be suitable for use with the aqueous botanical extract solutions described herein.
- The aqueous botanical extract solution can easily be atomized into an area to be treated, such as a bedroom or other room. As used herein, the term “atomized” means that the aqueous botanical extract solution is reduced to a spray form from liquid form, or volatilized. Atomization of the aqueous botanical extract solutions of the present invention can be accomplished utilizing various means including, for example, atomizers, aerosol sprayers, mechanical sprayers, misters, humidifiers, foggers, fumigating apparatuses, and the like. Both cold mist formulations and warm mist formulations including the aqueous botanical extract solutions are within the scope of the present invention. The aqueous botanical solution can also contain a small amount of dyes to color the product and/or a fragrance to impart a pleasing odor to the solution. Both of these additives potentially enhance consumer appeal of the product.
- The precise method of volatilizing the aqueous botanical extract solutions of the present invention to allow the botanical extract to contact the dust mite feces is not critical so long as the method employed can volatilize the aqueous solution sufficiently. Because house dust mites are typically very small in size, having a length of only about 250 microns to about 300 microns, it is preferable, although not critical, that the size of the droplets produced by the atomizing means be of such a size that they will sufficiently contact a majority of the dust mites and feces present in an area. As such, it is preferred that at least some of the atomized droplets of aqueous botanical extract solution have a medium drop size of no more than 1000 micrometers, more preferably no more than 500 micrometers, more preferably no more than about 200 micrometers, and most preferably no more than about 100 micrometers or less. These median drop sizes will allow a significant amount of the botanical extract to contact the dust mite feces present. Alternatively, a pesticidal composition could be introduced into the aqueous botanical extract solution and atomized simultaneously.
- In another embodiment of the present invention, the aqueous botanical extract solutions described herein can be used in combination with a pesticidal, acaricidal, or other suitable agent which kills the dust mites upon application or treatment. This combination of applications would serve to not only neutralize the dust mite feces present, but also reduce the number of living dust mites. For example, a pesticidal composition capable of killing dust mites upon contact could first be sprayed or otherwise applied to an area such as a bedroom, to kill dust mites. After the pesticidal application, the aqueous botanical extracts of the present invention could be atomized as described herein into the area to neutralize the feces of the dust mites. Although the aqueous botanical extract solutions described herein are highly effective in neutralizing the dust mite feces when used alone, when used in combination with an agent that kills dust mites, the combination is also highly effective in controlling the amount of dust mite allergens present.
- The present invention is illustrated by the following example which is merely for the purpose of illustration and is not to be regarded as limiting the scope of the invention or manner in which it may be practiced.
- In this example, numerous botanical extracts, both in solid (powder) form and in aqueous liquid form, were analyzed for serine protease inhibitory activity using the BAPNA-Trypsin Inhibition Test described herein. Although referred to throughout the Example as “v/v,” it should be realized that the concentration of the botanical extract would be referred to a “w/v” if the botanical extract was a solid. All of the botanical extracts tested were either in solid or aqueous form, and all liquids were soluble at a level of 10% by weight and all solids were essentially soluble at a level of 1% by weight.
- The botanical extracts, the name of the company where the botanical extract was purchased, the location of the company, the lot number (if available), the catalog number (if available) and the IC50 results for the botanical extracts tested in this Example are set forth in Table 1. Each liquid botanical extract listed in Table 1 was prepared for analysis as follows: A 10% (v/v) botanical extract solution in PBS (pH=7.4, Life Technologies, Rockville, Md.) was prepared by introducing 100 microliters of botanical extract into one milliliter of PBS. Serial dilutions of the 10% botanical solution in PBS were then made to prepare the following concentrations in addition to the 10% concentration; 5%, 2.5%, 1.25%, 0.63%, 0.31%, 0.16%, and 0.078%.
- Each solid botanical extract listed in Table 1 was prepared for analysis as follows: A 0.1% (w/v) botanical extract solution in PBS (pH=7.4) was prepared by introducing 1 milligram of botanical extract into one milliliter of PBS. Serial dilutions were prepared from this solution for a total of eight testing solutions.
- To the empty wells of a NUNC IMMUNO clear 96 well plate (VWR Scientific Products, Chicago, Ill.) was added 150 microliters of a 100 millimolar Tris buffer (Sigma Chemical Company, St. Louis, Mo.) with the pH adjusted to 8.0 utilizing HCl. Next, to allow for testing in triplicate, each concentration of botanical solution was added to three separate wells containing the Tris buffer. For control purposes, three wells had 25 microliters of the PBS solution introduced therein in place of any botanical extract solution.
- A stock solution of porcine pancreatic trypsin (15,200 units/milligram, Sigma Chemical Company, St. Louis, Mo.) was then prepared by adding the porcine pancreatic trypsin into 100 millimolar Tris buffer, pH adjusted to 8.0 with HCL to yield a concentration of 4 micrograms/milliliter. To each well of the plate was then added 25 microliters of the 4 micrograms/milliliter trypsin.
- After the porcine pancreatic trypsin was added to the wells of the plate, the well plates were incubated at room temperature for 15 minutes.
- After incubation, 50 microliters of a 5 millimolar solution of N-benzyl-arginine-p-nitroaniline (BAPNA) was added to each of the wells on the plate. The BAPNA substrate was prepared as a stock solution by preparing a 50 millimolar solution of BAPNA in dimethylsulfoxide and diluting the solution to a 5 millimolar working solution with deionized water. This resulted in a total concentration of botanical extracts being tested from a working stock of 10% (v/v) botanical solution of (1) 1%; (2) 0.5%; (3) 0.25%; (4) 0.125%; (5) 0.063%; (6) 0.031%; (7) 0.016%; and (8) 0.0078%.
- Immediately after the BAPNA was added, the plate was inserted into a SPECTRAmax PLUS 384 Microplate Reader (Molecular Devices, Sunnyvale, Calif.), and the optical density of each well was measured at 405 nanometers every 20 seconds for 5 minutes.
- After the optical density data was collected, an IC50 value was determined as set forth above for each botanical extract. The results are set forth in Table 1.
TABLE 1 Lot Number/ IC50 (×10−3 Botanical Company Location Catalog Number (% v/v or w/v)) Aloe Gel Tri-K Northvale, 970217/NA 1000 (no Industries N.J. effect) Apple Gattefosse Cedex, 23152 1000 (no Extract France effect) Apple Green Dragoco Totowa, N.J. 2/037050/L742477 11.5 Tea Arkin Dragoco Totowa, N.J. 2/032581/L647147 44.5 Special Arnica Dragoco Totowa, N.J. 2/034591/L641060 39 Special Avocado Dragoco Totowa, N.J. 2/034599/L645246 495 Avocado GW Dragoco Totowa, N.J. 2/031170/L603922 19 Black Dragoco Totowa, N.J. 2/036100/P331166 1000 (no Currant B effect) Black Dragoco Totowa, N.J. 2/037100/P331166 12.5 Currant Green Tea Cornflower Gattefosse Cedex, 23593/5009 1000 (no France effect) Cabbage Gattefosse Cedex, 22223 14.5 Rose France Extract. Calendula Gattefosse Cedex, 24243/5015 1000 (no MCF 774 France effect) Hydro Cat's Claw Bio-botanica Hauppauge, N.Y. 951341/9945A 16.5 Cemila Gattefosse Cedex, 22423 4.5 Oleifera France Extract Centella Bio-botanica Hauppauge, N.Y. 981177/9869A 176 Chamomile Bio-botanica Happauge, 980572/9831 1000 (no N.Y. effect) Chamomile Dragoco Totowa, N.J. 2/033021/694633 1000 (no Special effect) Chlorella Bio-botanica Hauppauge, 951289/9835 1000 (no N.Y. effect) Concombre Gattefosse Cedex, 19190 1000 (no GR 316 France effect) Cranberry B Dragoco Totowa, N.J. 2/036600/P15193 1000 (no effect) Cranberry Dragoco Totowa, N.J. 2/037600/4100723 6.5 Green Tea Dandelion Active Lewisville, S72041A/316310-11 88.5 organics- Tx. Glenn Corp Dong Quai Active Lewisville, S64418B/316320-11 1000 (no organics- Tx. effect) Glenn Corp Drago-Oat- Dragoco Totowa, N.J. 2/060900/25493 1000 (no Active effect) Garcinia Bio-botanica Happauge, 951283/9861 400 N.Y. Ginseng GR Gattefosse Cedex, 23268/5030 1000 (no 471 Hydro France effect) Glenn of Glenn Corp. St. Paul, 715 Oak Mn. Glenn of Glenn Corp. St. Paul, 1000 (no Orange Mn. effect) Gotu Kola Bio-botanica Happauge, 1000 (no PG 5:1 N.Y. effect) Grape Gattefosse Cedex, 22151 1000 (no Extract France effect) Grape Seed Active Lewisville, S76920B/318560-11 39 organics- Tx. Glenn Corp Grape Seed Dragoco Totowa, N.J. 2/03199/P17400 0.048 Extract Grapefruit Gattefosse Cedex, 23439 1000 (no France effect) Grapefruit Dragoco Totowa, N.J. 2/037150/L4100211 12.5 Green Tea Green Tea Bio-botanica Happauge, /9945 6 N.Y. Green Tea Active Lewisville, 308463/300230-94 140 Conc. organics- Tx. Glenn Corp Green Tea Dragoco Totowa, N.J. 2/031598/3066 0.15 Extra Green Tea Alban Muller Northvale, 7114309/ 15.6 HS Intl N.J. Hexaplant Chemisches Berlin, 732431/243 29.5 Richter Lab. Germany Hibiscus Dragoco Totowa, N.J. 2/033115/L651028 91.5 Special Hydrocotyl Gattefosse Cedex, 22842/5038 59 GR France Hydrolite-5 Dragoco Totowa, N.J. 2/016020/27033 1000 (no effect) Kiwi Gattefosse Cedex, 23311 1000 (no France effect) White Gattefosse Cedex, 22571/5040 1000 (no Nettle France effect) Lavender Gattefosse Cedex, 21189 20 France Lemon Gattefosse Cedex, 24126 1000 (no Extract France effect) Lily Gattefosse Cedex, 23410/5044 1000 (no France effect) Horse Gattefosse Cedex, 22043/5046 36 Chestnut France Horse Indena- Uppersaddle EG042 12.5 Chestnut International River, N.J. Sourcing German Indena- Uppersaddle EG004 1000 (no Chamomile International River, N.J. effect) Sourcing Matricaria Gattefosse Cedex, 21747 1000 (no Extract France effect) Sweet Gattefosse Cedex, 23316/5051 1000 (no Clover France effect) Milk Active Lewisville, S76894A/344000-11 215 Thistle organics- Tx. Glenn Corp Nab Willow Brooks S. 28392 1000 (no Bark Industries Plainfield, effect) Extract N.J. Orange Dragoco Totowa, N.J. 2/037400/P327911 9.5 Green Tea Phytexcell Croda Parsippany, 972/34656 245 Arnica N.J. Phytexcell Croda Parsippany, 1004/34684 1000 (no Mulberry N.J. effect) Phytoplenolin Bio-botanica Happauge, 980510/9870 760 N.Y. Purple Bio-botanica Happauge, 951338/9852 21 Coneflower N.Y. Raspberry Gattefosse Cedex, 23204 1000 (no France effect) Sage CL Dragoco Totowa, N.J. 2/033294/L640225 1000 (no effect) Sage GW Dragoco Totowa, N.J. 2/031770/L619604 20 Sage Dragoco Totowa, N.J. 2/033291/P312506 22 Special Sedaplant Chemisches Berlin, 732384/460 20 Richter Lab. Germany St. John's Dragoco Totowa, N.J. 2/032985/L658926 27 Wort W/S White Dragoco Totowa, N.J. 2/033141/L653324 1000 (no Mistle Toe effect) White Tea Dragoco Totowa, N.J. 10521/C-14235 0.098 50% Witchhazel Dragoco Totowa, N.J. 2/031340/L651033 99 GW Yarrow Bio-botanica Happauge, 951336/9958 80 N.Y. - As the data in Table 1 indicates, IC50 values determined for the botanical extracts tested ranged from 0.048 to 1000 (no inhibition detected). This would indicate that the botanical extract with an IC50 value of 0.048 (Grape Seed Extract) is highly effective in neutralizing dust mite feces whereas the botanical extract with a value of 1000 has little to no effect.
- In view of the above, it will be seen that the several objects of the invention are achieved. As various changes could be made in the above-described methods and compositions for neutralizing dust mite feces without departing from the scope of the invention, it is intended that all matter contained in the above description be interpreted as illustrative and not in a limiting sense.
Claims (12)
1. An aqueous composition for neutralizing dust mite feces, the composition comprising a water soluble botanical extract having a BAPNA-Trypsin Inhibition (IC50×10−3 (%, v/v or w/v)) of from about 0.01 to about 500.
2. The aqueous composition as set forth in claim 1 wherein the BAPNA-Trypsin Inhibition is from about 0.01 to about 200.
3. The aqueous composition as set forth in claim 1 wherein the BAPNA-Trypsin Inhibition is from about 0.01 to about 100.
4. The aqueous composition as set forth in claim 1 wherein the BAPNA-Trypsin Inhibition is from about 0.01 to about 20.
5. The aqueous composition as set forth in claim 1 wherein the BAPNA-Trypsin Inhibition is from about 0.01 to about 10.
6. The aqueous composition as set forth in claim 1 wherein the botanical extract has a solubility in water of at least about 10% (v/v or w/v).
7. The aqueous composition as set forth in claim 1 wherein the botanical extract is selected from the group consisting of Apple Green Tea, Arkin Special, Arnica Special, Avocado, Avocado GW, Black Currant Green Tea, Cabbage Rose, Cat's Claw, Cemila Oleifera, Centella, Cranberry Green Tea, Dandelion, Garcinia, Grape Seed, Grapefruit Green Tea, Green Tea, Green Tea Concentrate, Green Tea HS, Hexaplant Richter, Hibiscus Special, Hydrocotyle GR, Lavender, Horse Chestnut, Milk Thistle, Orange Green Tea, Phytexcell Arnica, Purple Coneflower, Sage GW, Sage Special, Sedaplant Richter, St. John's Wort, Witchhazel GW, Yarrow, Grape Seed Extract, Green Tea Extra, White Tea 50%, and combinations thereof.
8. A method of neutralizing dust mite feces, the method comprising:
introducing a protease inhibitory, water soluble agent into water to form a protease inhibitory solution; and
contacting the dust mite feces with the protease inhibitory solution.
9. The method as set forth in claim 8 wherein the protease inhibitory, water soluble agent is selected from the group consisting of Apple Green Tea, Arkin Special, Arnica Special, Avocado, Avocado GW, Black Currant Green Tea, Cabbage Rose, Cat's Claw, Cemila Oleifera, Centella, Cranberry Green Tea, Dandelion, Garcinia, Grape Seed, Grapefruit Green Tea, Green Tea, Green Tea Concentrate, Green Tea HS, Hexaplant Richter, Hibiscus Special, Hydrocotyle GR, Lavender, Horse Chestnut, Milk Thistle, Orange Green Tea, Phytexcell Arnica, Purple Coneflower, Sage GW, Sage Special, Sedaplant Richter, St. John's Wort, Witchhazel GW, Yarrow, Grape Seed Extract, Green Tea Extra, White Tea 50% and combinations thereof.
10. The method as set forth in claim 8 wherein the protease inhibitory water soluble agent has a BAPNA-Trypsin Inhibition (IC50×10−3 (%, v/v) of from about 0.01 to about 500.
11. A method of neutralizing dust mite feces, the method comprising:
solubilizing a botanical extact in a hydrophilic solvent and introducing the solubilized botanical extract into water to form an aqueous botanical extract solution, the botanical extract having a BAPNA-Trypsin Inhibition (IC50×10−3 (%, v/v or w/v)) of from about 0.01 to about 500; and
contacting the dust mite feces with the aqueous botanical extract solution.
12. The method as set forth in claim 11 wherein the hydrophilic solvent is selected from the group consisting of propylene glycol, butylene glycol, ethylene glycol, hexylene glycol, pentylene glycol, methyl propanediol, dipropylene glycol, glycerin, ethanol, isopropyl alcohol, and mixtures thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/349,832 US20060141074A1 (en) | 2002-11-19 | 2006-02-08 | Composition for neutralizing house dust mite feces |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/299,868 US7037535B2 (en) | 2002-11-19 | 2002-11-19 | Method and composition for neutralizing house dust mite feces |
US11/349,832 US20060141074A1 (en) | 2002-11-19 | 2006-02-08 | Composition for neutralizing house dust mite feces |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/299,868 Division US7037535B2 (en) | 2002-11-19 | 2002-11-19 | Method and composition for neutralizing house dust mite feces |
Publications (1)
Publication Number | Publication Date |
---|---|
US20060141074A1 true US20060141074A1 (en) | 2006-06-29 |
Family
ID=32297789
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/299,868 Expired - Fee Related US7037535B2 (en) | 2002-11-19 | 2002-11-19 | Method and composition for neutralizing house dust mite feces |
US11/349,832 Abandoned US20060141074A1 (en) | 2002-11-19 | 2006-02-08 | Composition for neutralizing house dust mite feces |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/299,868 Expired - Fee Related US7037535B2 (en) | 2002-11-19 | 2002-11-19 | Method and composition for neutralizing house dust mite feces |
Country Status (8)
Country | Link |
---|---|
US (2) | US7037535B2 (en) |
EP (1) | EP1562431A1 (en) |
JP (1) | JP2006506503A (en) |
KR (1) | KR20050084666A (en) |
AU (2) | AU2003237239B2 (en) |
BR (1) | BR0316035A (en) |
MX (1) | MXPA05004728A (en) |
WO (1) | WO2004045292A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006143700A (en) * | 2004-10-18 | 2006-06-08 | Maruzen Pharmaceut Co Ltd | Allergen inactivator and allergen inactivating substance |
JP5456734B2 (en) * | 2004-10-18 | 2014-04-02 | 丸善製薬株式会社 | Allergen inactivating agent and allergen inactivating material |
KR100821926B1 (en) * | 2005-09-21 | 2008-04-15 | 재단법인서울대학교산학협력재단 | Neutralizer of Mite Allergens Comprising Plant Extracts and the Compositions containing it |
JP5361123B2 (en) * | 2006-09-29 | 2013-12-04 | 住化エンビロサイエンス株式会社 | Allergen reducing composition and allergen reducing method |
JP2008088234A (en) * | 2006-09-29 | 2008-04-17 | Sumika Enviro-Science Co Ltd | Allergen-reducing composition and method for reducing allergen |
JP2008214501A (en) * | 2007-03-05 | 2008-09-18 | Japan Ecologia Co Ltd | House-dust mite allergen-reducing agent |
KR20130071769A (en) * | 2011-12-21 | 2013-07-01 | 쓰리엠 이노베이티브 프로퍼티즈 캄파니 | Anti-allergen composition and spray formulation comprising the same |
KR20170089902A (en) * | 2014-11-27 | 2017-08-04 | 인큐팜 그룹 에스디엔 비에이치디 | Composition comprising a pentose and polyphenolic compound |
KR101789051B1 (en) | 2015-09-18 | 2017-10-23 | 안용준 | Dust mite allergen inactivator and composition thereof |
CN113388459B (en) * | 2021-05-26 | 2022-03-01 | 宁波芮颂生物科技有限公司 | Preparation method of anti-cat and dog allergen finishing composition solution |
Citations (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2705171A (en) * | 1952-08-26 | 1955-03-29 | Z & W Machine Products Inc | Fog spray applicator |
US2795799A (en) * | 1956-09-04 | 1957-06-18 | Dickerman Joseph | Automatic activating device for aerosol containers |
US3068492A (en) * | 1961-02-16 | 1962-12-18 | Nathaniel W Price | Flush tank attachment for lever operation of atomizer deodorant cans |
US3074891A (en) * | 1960-03-24 | 1963-01-22 | Fritzsche Brothers Inc | Compositions and methods for the deodorization of spaces |
US3169905A (en) * | 1961-05-15 | 1965-02-16 | William H Lambert | Sanitizing composition and method of use |
US4100324A (en) * | 1974-03-26 | 1978-07-11 | Kimberly-Clark Corporation | Nonwoven fabric and method of producing same |
US4255337A (en) * | 1978-09-08 | 1981-03-10 | Givaudan Corporation | Novel odorants and flavorants |
US4506831A (en) * | 1982-07-09 | 1985-03-26 | Nattermann & Cie Gmbh | Process for the spray application of plant protective spray mixtures and packing units for concentrates |
US4609547A (en) * | 1980-04-15 | 1986-09-02 | Beecham Group P.L.C. | Anti-allergic compositions and their use |
US4806526A (en) * | 1984-07-11 | 1989-02-21 | University Of Sydney | Antiallergenic agent |
US4874129A (en) * | 1988-06-30 | 1989-10-17 | Dow Corning Corporation | Multi-laminate fragrance release device |
US4961532A (en) * | 1989-07-07 | 1990-10-09 | Dow Corning Corporation | Fragrance release device containing a highly adsorptive copolymer |
US5141803A (en) * | 1988-06-29 | 1992-08-25 | Sterling Drug, Inc. | Nonwoven wipe impregnating composition |
US5152996A (en) * | 1990-12-10 | 1992-10-06 | Eastman Kodak Company | Nonwoven wipes impregnated with an aqueous solution of a zinc acetate peroxide and a surfactant |
US5330756A (en) * | 1990-10-18 | 1994-07-19 | Steuart Gary M | Polyphase fluid extraction process, resulting products and methods of use |
US5472700A (en) * | 1993-10-20 | 1995-12-05 | Fmc Corporation | Combinations of neem seed extract and bifenthrin for control of ectoparasites on animals |
US5497944A (en) * | 1990-03-21 | 1996-03-12 | Dmw (Technology) Limited | Atomising devices and methods |
US5587358A (en) * | 1994-05-09 | 1996-12-24 | Asahi Kasei Kogyo Kabushiki Kaisha | Potentiators of antimicrobial activity |
US5601833A (en) * | 1993-12-30 | 1997-02-11 | L'oreal | Protective, nutritive and/or firming composition for the simultaneous treatment of the surface layers and deep layers of the skin, and use thereof |
US5604262A (en) * | 1995-03-22 | 1997-02-18 | Research Corporation Technologies, Inc. | Topical antimicrobial agents |
US5648083A (en) * | 1995-02-10 | 1997-07-15 | The Procter & Gamble Company | Personal care compositions and wipe products containing the compositions |
US5656278A (en) * | 1993-09-30 | 1997-08-12 | The Boots Company Plc | Dermatological and cosmetic compositions |
US5723138A (en) * | 1996-05-02 | 1998-03-03 | Bae; Jae-Hyun | Skin-adhesive cosmetics for removing wrinkles, containing vitamins and aloe extract |
US5804168A (en) * | 1997-01-29 | 1998-09-08 | Murad; Howard | Pharmaceutical compositions and methods for protecting and treating sun damaged skin |
US5830916A (en) * | 1996-05-23 | 1998-11-03 | Duke University | Inhibitor of ceramidase |
US5888527A (en) * | 1995-05-11 | 1999-03-30 | Matsushita Seiko Co., Ltd. | Gargling cup, antiviral mask, antiviral filter, antifungal, antibacterial, and antiviral filter air cleaner and air-cleaner humidifier |
US5891465A (en) * | 1996-05-14 | 1999-04-06 | Biozone Laboratories, Inc. | Delivery of biologically active material in a liposomal formulation for administration into the mouth |
US5906992A (en) * | 1996-11-21 | 1999-05-25 | Colgate Palmolive Company | Foam cleaning compositions |
US5916917A (en) * | 1997-02-20 | 1999-06-29 | Reckitt & Colman Inc. | Dust mite control compositions containing benzyl benzoate and alcohol |
US5916573A (en) * | 1995-08-21 | 1999-06-29 | Spiers; Samantha M. | Topical treatment of the skin with a grapeseed oil composition |
US5935598A (en) * | 1996-06-19 | 1999-08-10 | Becton Dickinson Research Center | Iontophoretic delivery of cell adhesion inhibitors |
US5985300A (en) * | 1997-03-20 | 1999-11-16 | Chesebrough-Pond's Usa Co. | Delivery of skin benefit agents via adhesive strips |
US6028018A (en) * | 1996-07-24 | 2000-02-22 | Kimberly-Clark Worldwide, Inc. | Wet wipes with improved softness |
US6060075A (en) * | 1997-08-27 | 2000-05-09 | Vittal Mallya Scientific Research Foundation | Check mite composition and a process for preparing the same |
US6117440A (en) * | 1997-08-06 | 2000-09-12 | Reckitt Benckiser Inc. | Compositions effective for controlling dust mites and the allergens produced by dust mites |
US6174519B1 (en) * | 1997-12-24 | 2001-01-16 | Shaklee Corporation | Composition for protecting skin from damaging effects of ultraviolet light |
US6235737B1 (en) * | 2000-01-25 | 2001-05-22 | Peter Styczynski | Reduction of hair growth |
US6258355B1 (en) * | 1996-11-22 | 2001-07-10 | Vsl Pharmaceuticals Inc. | Sphingomyelinase compositions and use thereof |
US20010048097A1 (en) * | 2000-03-14 | 2001-12-06 | Keiichiro Inui | Method for denaturing allergens |
US20020015668A1 (en) * | 2000-07-31 | 2002-02-07 | Dell'acqua Lucio | Device for the atomization of cleaning and disinfecting liquids |
US20020022043A1 (en) * | 1999-12-28 | 2002-02-21 | Miller Jeffrey D. | Method for killing house dust mites in clothing and other soft materials |
US20020043571A1 (en) * | 2000-09-05 | 2002-04-18 | Markus Nowotny | Method and device for atomizing liquids |
US20020187168A1 (en) * | 2001-03-28 | 2002-12-12 | Jensen Claude Jarkae | Morinda Citrifolia (Noni) enhanced cosmetic skin care toner |
US20020192314A1 (en) * | 2001-03-06 | 2002-12-19 | Cho Suk H. | Dietary supplement compositions |
US20030124062A1 (en) * | 2000-04-17 | 2003-07-03 | Satoshi Mekata | Intermittently sprayed aerosol product for skin |
US20030206979A1 (en) * | 2000-12-22 | 2003-11-06 | Kimberly-Clark Worldwide, Inc. | Absorbent articles with compositions for reducing irritation response |
US20040057867A1 (en) * | 2000-12-22 | 2004-03-25 | Nutricia N.V. | Pasteurizing or sterilizing |
US6780825B2 (en) * | 2001-02-06 | 2004-08-24 | Playtex Products, Inc. | Cleansing compositions with milk protein and aromatherapy |
US6800247B1 (en) * | 1997-09-25 | 2004-10-05 | Reckitt Benckiser (Uk) Limited | Deactivants for dust mite allergens |
US7115283B2 (en) * | 2003-05-06 | 2006-10-03 | Access Business Group International Llc | Preparations for sustained release of nutraceuticals and methods of controllably releasing nutraceuticals |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US22043A (en) * | 1858-11-09 | Warth | ||
JPS59166585A (en) | 1983-03-10 | 1984-09-19 | Osaka Chem Lab | Antioxidant |
JP2632530B2 (en) | 1988-02-15 | 1997-07-23 | 日本ユニカー株式会社 | Plastic film packaging material with excellent freshness retention and deodorization |
US4941995A (en) | 1988-07-05 | 1990-07-17 | Scott Paper Company | Natural preservative composition for wet wipes |
JP3019325B2 (en) | 1989-06-26 | 2000-03-13 | エステー化学株式会社 | Wet tissue |
JPH0725657B2 (en) | 1990-02-09 | 1995-03-22 | 花王株式会社 | Hair treatment composition |
US5512283A (en) * | 1990-07-06 | 1996-04-30 | Allergene, Inc. | Methods for the selective suppression of an immune response to dust mite der Pi |
CN1071844A (en) | 1992-12-18 | 1993-05-12 | 张洪昌 | From green tea, extract the method for natural biological activator |
JPH06279273A (en) * | 1993-03-30 | 1994-10-04 | Earth Chem Corp Ltd | Method for removing allergen from environment and antiallergic composition |
JPH07228892A (en) | 1994-02-18 | 1995-08-29 | Kao Corp | Detergent composition for hard surface |
FR2724818B1 (en) | 1994-09-28 | 1999-05-07 | Phytodif Lab | ACARICIDAL COMPOSITION CONTAINING GLUTARALDEHYDE |
KR970008991B1 (en) | 1994-12-22 | 1997-06-03 | 주식회사 엘지화학 | Composition of tablet type bowl cleaner |
AUPN056395A0 (en) | 1995-01-16 | 1995-02-09 | University Of Melbourne, The | Production of genetically transformed forage grasses |
JPH08217658A (en) | 1995-02-15 | 1996-08-27 | Kanebo Ltd | Ceramide synthesis accelerator |
JP3122333B2 (en) | 1995-02-28 | 2001-01-09 | 株式会社薬理学中央研究所 | Novel production method of sphingomyelin and ceramide using erythrocyte as raw material and therapeutic agent or cosmetic containing ceramide |
JPH08268859A (en) | 1995-04-03 | 1996-10-15 | Kao Corp | Cosmetic for preventing and improving wrinkle |
ES2230566T3 (en) * | 1995-07-17 | 2005-05-01 | Medivir Uk Ltd | INHIBITORS OF CYSTEINE PROTEASE FOR THE TREATMENT OF ALLERGIC DISEASES MEDIATED BY IMMUNOGLOBULIN E (IGE). |
JPH09110615A (en) | 1995-10-17 | 1997-04-28 | Mitsui Norin Kk | Disinfectant containing catechins blended therein |
ES2165525T3 (en) * | 1995-11-01 | 2002-03-16 | Kimberly Clark Co | TOWELS IMPREGNATED ANTIMICROBIAL SUBSTANCES. |
JPH09194317A (en) | 1996-01-23 | 1997-07-29 | Sumitomo Chem Co Ltd | Agent for controlling house dust mite |
AU3495897A (en) | 1996-07-24 | 1998-02-10 | Kimberly-Clark Worldwide, Inc. | Fibrous sheet materials containing oat extract |
US6027716A (en) | 1997-04-02 | 2000-02-22 | Farmo-Nat Ltd. | Synergistic herbal extracts |
AU6877398A (en) | 1997-04-04 | 1998-10-30 | Optiva Corp. | Antimicrobial agents for oral hygiene products |
US5939050A (en) | 1997-04-04 | 1999-08-17 | Optiva Corp. | Antimicrobial compositions |
US6063387A (en) | 1997-04-17 | 2000-05-16 | Elizabeth Arden Co., Division Of Conopco, Inc. | Anhydrous cosmetic composition with ceramides for firming skin |
JP3928224B2 (en) | 1997-10-08 | 2007-06-13 | 住友化学株式会社 | Acaricidal composition |
JPH11130627A (en) | 1997-10-27 | 1999-05-18 | Tsunetaka Yokoyama | Production and use of medicinal pack agent consisting of tea leaf fine powder and extract of powdered tea or tea as main component |
JPH11139959A (en) | 1997-11-10 | 1999-05-25 | Tsunetaka Yokoyama | Production of skin cleaning cosmetic, facial washing preparation and soap for nutrient medicine containing vegetable tea leaf fine powder, ground green tea and tea essence, amino acid, vitamin and oligosaccharide mixed therein |
JPH11228325A (en) | 1998-02-17 | 1999-08-24 | Hiromi Nishii | Liquid agent composition compounded with plant extract |
JPH11292710A (en) | 1998-04-03 | 1999-10-26 | T Pooru Kk | Germicidal composition |
CA2324556C (en) | 1998-04-17 | 2005-01-11 | Pillarisetti Venkata Subba Rao | An environment friendly acaricide formulation |
JPH11332778A (en) | 1998-05-22 | 1999-12-07 | Kao Corp | Wiping sheet |
DE19824727A1 (en) | 1998-06-03 | 1999-12-09 | Beiersdorf Ag | Cosmetic or dermatological preparations containing catechins or green tea extract |
DE19824683A1 (en) | 1998-06-03 | 1999-12-09 | Grewe Helmut F | Use of ethereal oil in spray form for control of mites, e.g. house dust mite |
DE19824680A1 (en) | 1998-06-03 | 1999-12-09 | Grewe Helmut F | Use of ethereal oil in depot form for control of mites, e.g. house dust mite |
DE19827624A1 (en) | 1998-06-20 | 1999-12-23 | Beiersdorf Ag | Use of catechols or plant extracts containing them in intensifying natural skin tanning or in stimulating melanogenesis |
US6319958B1 (en) | 1998-06-22 | 2001-11-20 | Wisconsin Alumni Research Foundation | Method of sensitizing microbial cells to antimicrobial compound |
JP2000053923A (en) | 1998-08-11 | 2000-02-22 | Sekisui Chem Co Ltd | Floor-polishing agent having miticidal effect |
JP2000063262A (en) | 1998-08-19 | 2000-02-29 | Osaka Yakuhin Kenkyusho:Kk | Antimicrobial cosmetic composition |
JP3343516B2 (en) | 1998-08-29 | 2002-11-11 | 株式会社大貴 | Sanitary sheets and method for producing the same |
JP3816262B2 (en) | 1998-09-30 | 2006-08-30 | 花王株式会社 | Ceramide production promoter |
JP2000153533A (en) | 1998-11-20 | 2000-06-06 | Honda Motor Co Ltd | Composite integrally molded product and molding method thereof |
FR2786694B1 (en) | 1998-12-03 | 2002-09-27 | Serobiologiques Lab Sa | USE OF PLANT EXTRACTS, PARTICULARLY ANTI-RADICAL ACTION AND COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING SUCH EXTRACTS |
WO2001083666A2 (en) | 2000-05-04 | 2001-11-08 | Kimberly-Clark Worldwide, Inc. | Ion-sensitive, water-dispersible polymers, a method of making same and items using same |
DE19903716A1 (en) | 1999-01-30 | 2000-08-03 | Henkel Kgaa | Antioxidant skin care products |
JP2001009950A (en) | 1999-06-28 | 2001-01-16 | Mitsubishi Chemicals Corp | Air permeable laminate and sanitary article |
AR020578A1 (en) | 1999-06-28 | 2002-05-15 | Ecosmart Technologies Inc | METHOD TO KILL OR CONTROL ACAROS OF DOMESTIC POWDER |
US6506394B1 (en) | 1999-06-30 | 2003-01-14 | Kimberly-Clark Worldwide, Inc. | Delivery of a botanical extract to a treated substrate for transfer to skin |
WO2001001949A1 (en) | 1999-07-01 | 2001-01-11 | Johnson And Johnson Consumer Companies, Inc. | Cleansing compositions |
US6410039B1 (en) | 1999-09-15 | 2002-06-25 | First Scientific, Inc. | Protective topical composition, products including the same, and methods |
EP1217984B1 (en) | 1999-10-08 | 2004-12-22 | Coty B.V. | Cosmetic preparation of active substances with a synergistically increased radical protection factor |
JP4139545B2 (en) | 2000-03-17 | 2008-08-27 | 花王株式会社 | Skin cosmetics |
GB2363074B (en) | 2000-04-07 | 2003-04-09 | Reckitt Benckiser | Method of deactivating dust mite allergens |
CN1111068C (en) | 2000-07-27 | 2003-06-11 | 上海北医大生物科技有限公司 | Strong anti-oxidative composite capsule of grape seed extract OPC and its producing method |
DE60031726T2 (en) | 2000-09-29 | 2007-09-06 | The Procter & Gamble Company, Cincinnati | COMPOSITIONS FOR NEUTRALIZING ALLERGENS |
DE10104479C1 (en) | 2001-01-31 | 2002-09-12 | Gerhard Knapp | Combination of agents used for inhibiting mite droppings, e.g. for spraying mattress or bed, consists of auxilase, water, anionic surfactant, fragrance and preservative |
CA2432728A1 (en) | 2001-02-08 | 2002-08-15 | Akikazu Yoshikawa | Allergen neutralization compositions containing aluminum ions |
-
2002
- 2002-11-19 US US10/299,868 patent/US7037535B2/en not_active Expired - Fee Related
-
2003
- 2003-05-23 WO PCT/US2003/016435 patent/WO2004045292A1/en active Application Filing
- 2003-05-23 KR KR1020057007928A patent/KR20050084666A/en not_active Application Discontinuation
- 2003-05-23 MX MXPA05004728A patent/MXPA05004728A/en active IP Right Grant
- 2003-05-23 BR BR0316035-1A patent/BR0316035A/en not_active IP Right Cessation
- 2003-05-23 JP JP2004553408A patent/JP2006506503A/en not_active Abandoned
- 2003-05-23 AU AU2003237239A patent/AU2003237239B2/en not_active Ceased
- 2003-05-23 EP EP03736705A patent/EP1562431A1/en not_active Withdrawn
-
2006
- 2006-02-08 US US11/349,832 patent/US20060141074A1/en not_active Abandoned
-
2008
- 2008-07-21 AU AU2008203235A patent/AU2008203235B2/en not_active Ceased
Patent Citations (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2705171A (en) * | 1952-08-26 | 1955-03-29 | Z & W Machine Products Inc | Fog spray applicator |
US2795799A (en) * | 1956-09-04 | 1957-06-18 | Dickerman Joseph | Automatic activating device for aerosol containers |
US3074891A (en) * | 1960-03-24 | 1963-01-22 | Fritzsche Brothers Inc | Compositions and methods for the deodorization of spaces |
US3068492A (en) * | 1961-02-16 | 1962-12-18 | Nathaniel W Price | Flush tank attachment for lever operation of atomizer deodorant cans |
US3169905A (en) * | 1961-05-15 | 1965-02-16 | William H Lambert | Sanitizing composition and method of use |
US4100324A (en) * | 1974-03-26 | 1978-07-11 | Kimberly-Clark Corporation | Nonwoven fabric and method of producing same |
US4255337A (en) * | 1978-09-08 | 1981-03-10 | Givaudan Corporation | Novel odorants and flavorants |
US4609547A (en) * | 1980-04-15 | 1986-09-02 | Beecham Group P.L.C. | Anti-allergic compositions and their use |
US4506831A (en) * | 1982-07-09 | 1985-03-26 | Nattermann & Cie Gmbh | Process for the spray application of plant protective spray mixtures and packing units for concentrates |
US4806526A (en) * | 1984-07-11 | 1989-02-21 | University Of Sydney | Antiallergenic agent |
US5141803A (en) * | 1988-06-29 | 1992-08-25 | Sterling Drug, Inc. | Nonwoven wipe impregnating composition |
US4874129A (en) * | 1988-06-30 | 1989-10-17 | Dow Corning Corporation | Multi-laminate fragrance release device |
US4961532A (en) * | 1989-07-07 | 1990-10-09 | Dow Corning Corporation | Fragrance release device containing a highly adsorptive copolymer |
US5497944A (en) * | 1990-03-21 | 1996-03-12 | Dmw (Technology) Limited | Atomising devices and methods |
US5330756A (en) * | 1990-10-18 | 1994-07-19 | Steuart Gary M | Polyphase fluid extraction process, resulting products and methods of use |
US5152996A (en) * | 1990-12-10 | 1992-10-06 | Eastman Kodak Company | Nonwoven wipes impregnated with an aqueous solution of a zinc acetate peroxide and a surfactant |
US5656278A (en) * | 1993-09-30 | 1997-08-12 | The Boots Company Plc | Dermatological and cosmetic compositions |
US5472700A (en) * | 1993-10-20 | 1995-12-05 | Fmc Corporation | Combinations of neem seed extract and bifenthrin for control of ectoparasites on animals |
US5601833A (en) * | 1993-12-30 | 1997-02-11 | L'oreal | Protective, nutritive and/or firming composition for the simultaneous treatment of the surface layers and deep layers of the skin, and use thereof |
US5587358A (en) * | 1994-05-09 | 1996-12-24 | Asahi Kasei Kogyo Kabushiki Kaisha | Potentiators of antimicrobial activity |
US5648083A (en) * | 1995-02-10 | 1997-07-15 | The Procter & Gamble Company | Personal care compositions and wipe products containing the compositions |
US5604262A (en) * | 1995-03-22 | 1997-02-18 | Research Corporation Technologies, Inc. | Topical antimicrobial agents |
US5888527A (en) * | 1995-05-11 | 1999-03-30 | Matsushita Seiko Co., Ltd. | Gargling cup, antiviral mask, antiviral filter, antifungal, antibacterial, and antiviral filter air cleaner and air-cleaner humidifier |
US5916573A (en) * | 1995-08-21 | 1999-06-29 | Spiers; Samantha M. | Topical treatment of the skin with a grapeseed oil composition |
US5723138A (en) * | 1996-05-02 | 1998-03-03 | Bae; Jae-Hyun | Skin-adhesive cosmetics for removing wrinkles, containing vitamins and aloe extract |
US5891465A (en) * | 1996-05-14 | 1999-04-06 | Biozone Laboratories, Inc. | Delivery of biologically active material in a liposomal formulation for administration into the mouth |
US5851782A (en) * | 1996-05-23 | 1998-12-22 | Duke University | Inhibitors of ceramidase |
US5830916A (en) * | 1996-05-23 | 1998-11-03 | Duke University | Inhibitor of ceramidase |
US5935598A (en) * | 1996-06-19 | 1999-08-10 | Becton Dickinson Research Center | Iontophoretic delivery of cell adhesion inhibitors |
US6028018A (en) * | 1996-07-24 | 2000-02-22 | Kimberly-Clark Worldwide, Inc. | Wet wipes with improved softness |
US5906992A (en) * | 1996-11-21 | 1999-05-25 | Colgate Palmolive Company | Foam cleaning compositions |
US6258355B1 (en) * | 1996-11-22 | 2001-07-10 | Vsl Pharmaceuticals Inc. | Sphingomyelinase compositions and use thereof |
US5804168A (en) * | 1997-01-29 | 1998-09-08 | Murad; Howard | Pharmaceutical compositions and methods for protecting and treating sun damaged skin |
US5916917A (en) * | 1997-02-20 | 1999-06-29 | Reckitt & Colman Inc. | Dust mite control compositions containing benzyl benzoate and alcohol |
US5985300A (en) * | 1997-03-20 | 1999-11-16 | Chesebrough-Pond's Usa Co. | Delivery of skin benefit agents via adhesive strips |
US6117440A (en) * | 1997-08-06 | 2000-09-12 | Reckitt Benckiser Inc. | Compositions effective for controlling dust mites and the allergens produced by dust mites |
US6060075A (en) * | 1997-08-27 | 2000-05-09 | Vittal Mallya Scientific Research Foundation | Check mite composition and a process for preparing the same |
US6800247B1 (en) * | 1997-09-25 | 2004-10-05 | Reckitt Benckiser (Uk) Limited | Deactivants for dust mite allergens |
US6235272B1 (en) * | 1997-12-24 | 2001-05-22 | Shaklee Corporation | Composition for protecting skin from damaging effects of ultraviolet light |
US6174519B1 (en) * | 1997-12-24 | 2001-01-16 | Shaklee Corporation | Composition for protecting skin from damaging effects of ultraviolet light |
US20020022043A1 (en) * | 1999-12-28 | 2002-02-21 | Miller Jeffrey D. | Method for killing house dust mites in clothing and other soft materials |
US6235737B1 (en) * | 2000-01-25 | 2001-05-22 | Peter Styczynski | Reduction of hair growth |
US20010048097A1 (en) * | 2000-03-14 | 2001-12-06 | Keiichiro Inui | Method for denaturing allergens |
US20030124062A1 (en) * | 2000-04-17 | 2003-07-03 | Satoshi Mekata | Intermittently sprayed aerosol product for skin |
US20020015668A1 (en) * | 2000-07-31 | 2002-02-07 | Dell'acqua Lucio | Device for the atomization of cleaning and disinfecting liquids |
US6651898B2 (en) * | 2000-09-05 | 2003-11-25 | Roche Vitamins Inc. | Method and device for atomizing liquids |
US20020043571A1 (en) * | 2000-09-05 | 2002-04-18 | Markus Nowotny | Method and device for atomizing liquids |
US20030206979A1 (en) * | 2000-12-22 | 2003-11-06 | Kimberly-Clark Worldwide, Inc. | Absorbent articles with compositions for reducing irritation response |
US20040057867A1 (en) * | 2000-12-22 | 2004-03-25 | Nutricia N.V. | Pasteurizing or sterilizing |
US6780825B2 (en) * | 2001-02-06 | 2004-08-24 | Playtex Products, Inc. | Cleansing compositions with milk protein and aromatherapy |
US20020192314A1 (en) * | 2001-03-06 | 2002-12-19 | Cho Suk H. | Dietary supplement compositions |
US20020187168A1 (en) * | 2001-03-28 | 2002-12-12 | Jensen Claude Jarkae | Morinda Citrifolia (Noni) enhanced cosmetic skin care toner |
US7115283B2 (en) * | 2003-05-06 | 2006-10-03 | Access Business Group International Llc | Preparations for sustained release of nutraceuticals and methods of controllably releasing nutraceuticals |
Also Published As
Publication number | Publication date |
---|---|
WO2004045292A1 (en) | 2004-06-03 |
AU2008203235A1 (en) | 2008-08-07 |
US7037535B2 (en) | 2006-05-02 |
AU2003237239B2 (en) | 2008-05-01 |
KR20050084666A (en) | 2005-08-26 |
MXPA05004728A (en) | 2005-08-03 |
AU2008203235B2 (en) | 2009-06-04 |
EP1562431A1 (en) | 2005-08-17 |
BR0316035A (en) | 2005-09-13 |
JP2006506503A (en) | 2006-02-23 |
US20040096525A1 (en) | 2004-05-20 |
AU2003237239A1 (en) | 2004-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2008203235B2 (en) | Method and composition for neutralizing house dust mite feces | |
US4806526A (en) | Antiallergenic agent | |
US7439218B2 (en) | Disinfectant compositions comprising an orange oil mixture and methods of use thereof | |
CA2383541C (en) | Terpene based pesticide treatments for killing terrestrial arthropods including, amongst others, lice, lice eggs, mites and ants | |
CN111685134A (en) | Mite-removing and bacterium-inhibiting composition containing plant essential oil and application thereof | |
KR20150056537A (en) | Compositions and methods for the attraction and repulsion of insects | |
US4977142A (en) | Antiallergenic agent | |
US20090214679A1 (en) | Pest-combating compositions comprising soy methyl ester | |
US6060075A (en) | Check mite composition and a process for preparing the same | |
CA2324556C (en) | An environment friendly acaricide formulation | |
KR101789051B1 (en) | Dust mite allergen inactivator and composition thereof | |
JP2002128659A (en) | Spray for treating house dust | |
US8025905B2 (en) | Method for reducing allergencity in indoor spaces | |
KR20210140923A (en) | Aromatic composition for relieving itch of companion animal | |
CN112602730B (en) | Mite-killing spray and preparation method thereof | |
US20070053898A1 (en) | Method for reducing allergencity in indoor spaces | |
JP2021187754A (en) | Composition for preventing attachment of fine particles as well as method for preventing attachment of fine particles to object to be processed by using the same and method for preventing disease caused by fine particles | |
CN115176819A (en) | Atomized disinfectant of tea tree oil | |
CN113615717A (en) | Acaricide containing plant essential oil, and its application method and application | |
KR20230122294A (en) | Natural disinfectant composition with excellent deodorization and coating effect | |
KR20050116215A (en) | Avoidance compositions and extermination of a mite(dermatophagoides farinae, dermatophagoides pisronyssinus, etc) by a red algae extract | |
CN115500361A (en) | Water-based product containing peppermint leaf oil and mite killing application thereof | |
CN112353830A (en) | Extraction method and application of effective part of chrysanthemum indicum leaf for removing mites | |
CN116473855A (en) | Portable mosquito repellent wet tissue containing menthanediol for infants and preparation method thereof | |
HU219192B (en) | Synergetic fungicidal composition containing two active ingredient and method for its use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |